June 5, 2019
In recent years in Vietnam, new policies and changes in the law have led to many situations where foreign companies are no longer allowed to operate as representative offices (ROs), or find that it is no longer optimal to do so. As a result, many companies are converting or considering the conversion of their ROs into full subsidiaries or “foreign-invested enterprises” (FIEs). This has been an especially hot topic in the pharmaceutical sector after changes brought on in 2017 by new legislation.